Recent studies have shown that FXR can ameliorate renal fibrosis caused by liver fibrosis [20–22] and unilateral ureteral obstruction models by inhibiting α-SMA expression [36]. The gene discussed is NR1H4; the disease is Hepatic fibrosis.